| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $7,874,200 | -20,000 | -0.39% | $393.71 | 5,113,019 | 29 Feb 2024 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $32,150,400 | -80,000 | -1.6% | $401.88 | 5,033,019 | 01 Mar 2024 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.41 to $401.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.88. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |